Managed by Theleme Partners Llp • Latest filing Q4 2025
Overlap peers will appear here as data populates
Related fund suggestions coming soon.
| — |
| 5 | M MRNA — | $632.6M | 6.36M | 0.00% | — |
| 6 | M MRNA — | $609.7M | 5.90M | 0.00% | — |
| 7 | W | $439M | 10.29M | 0.00% | — |
| 8 | M MRNA — | $418.4M | 6.26M | 0.00% | — |
| 9 | W | $416.3M | 11.14M | 0.00% | — |
| 10 | S | $387.4M | 5.63M | 0.00% | — |
| 11 | S | $374.4M | 6.82M | 0.00% | — |
| 12 | S | $366.8M | 5.07M | 0.00% | — |
| 13 | W | $344.9M | 7.01M | 0.00% | — |
| 14 | S | $342.7M | 6.05M | 0.00% | — |
| 15 | W | $342.3M | 5.91M | 0.00% | — |
| 16 | S | $339.4M | 4.61M | 0.00% | — |
| 17 | W | $286.3M | 7.01M | 0.00% | — |
| 18 | M META — | $284.5M | 431.1K | 0.00% | — |
| 19 | W | $276.3M | 4.65M | 0.00% | — |
| 20 | S | $272.4M | 4.20M | 0.00% | — |